Capricor Therapeutics
CAPR
CAPR
75 hedge funds and large institutions have $127M invested in Capricor Therapeutics in 2024 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
23% more funds holding
Funds holding: 61 → 75 (+14)
5.63% more ownership
Funds ownership: 20.1% → 25.72% (+5.6%)
Holders
75
Holding in Top 10
1
Calls
$33.4M
Puts
$22.9M
Top Buyers
| 1 | +$5.13M | |
| 2 | +$4.56M | |
| 3 | +$4.33M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.81M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$2.32M |
Top Sellers
| 1 | -$5.85M | |
| 2 | -$656K | |
| 3 | -$426K | |
| 4 |
Man Group
London,
United Kingdom
|
-$404K |
| 5 |
LPL Financial
San Diego,
California
|
-$334K |